Cytochrome P-450 CYP2C19 Inhibitors (moderate)
- Name
- Cytochrome P-450 CYP2C19 Inhibitors (moderate)
- Accession Number
- DBCAT002640
- Description
Not Available
- Drugs
Drug Drug Description Sertraline A selective serotonin reuptake inhibitor (SSRI) indicated to treat major depressive disorder, social anxiety disorder and many other psychiatric conditions. Efavirenz A non-nucleoside reverse transcriptase inhibitor used to treat HIV infection or prevent the spread of HIV. Armodafinil A stimulant used to improve wakefulness in adult patients with excessive sleepiness associated with obstructive sleep apnea, narcolepsy, or shift work disorder. Eslicarbazepine acetate An anticonvulsant agent used as an adjunct to treat partial-onset seizures in patients with inadequate clinical response to conventional antiepileptic therapy. Abiraterone An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer. Zucapsaicin A topical analgesic used as an adjunct to relieve severe pain of osteoarthritis of the knee in selected adult patients. Ticlopidine A platelet aggregation inhibitor used in the prevention of conditions associated with thrombi, such as stroke and transient ischemic attacks (TIA). Cisapride A medication used to treat heartburn associated with GERD. Zafirlukast A leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma. - Drugs & Drug Targets